Satisfactory Q3 result in special circumstances – capital adequacy continued to strengthen Nov 5, 2026 01:45AM

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE, 5 NOVEMBER 2026 AT 8:45 AM, INTERIM REPORT

Satisfactory Q3 result in special circumstances – capital adequacy continued to strengthen

This release is a summary of the January–September 2026 interim report of Oma Savings Bank Plc (“OmaSp” or “the Company”). The report is available in full as a PDF attachment to this stock exchange release and on the Company’s website at http://www.omasp.fi.

CEO Karri Alameri:

On 9 July... (continue reading...)


ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business Nov 5, 2026 01:33AM
  • Egetis Therapeutics’ lead asset, EMCITATE®, is the first and only approved treatment in U.S. and Europe for peripheral thyrotoxicosis associated with MCT8 deficiency, a rare genetic disorder, impacting approximately 1 in 70K males
  • Supported by ANI’s proven track record in Rare Disease, EMCITATE® has potential to reach over $300 million in peak sales in its approved indication, with U.S. and EU Orphan Drug Exclusivity and patent protection into 2045
  • Combines ANI’s... (continue reading...)

Civinity AB continues its note programme: a new tranche of the note issue worth up to EUR 8,000,000, intended to finance the Group’s further expansion Nov 5, 2026 01:31AM

AB “Civinity” (hereinafter also referred to as the ‘Issuer’) is issuing a new tranche of notes worth up to EUR 8,000,000 (with a possibility to increase this amount depending on the demand) pursuant to the base prospectus (the ‘Prospectus’) of EUR 50,000,000 Notes Programme for the Issuance of Notes (ISIN LT0000134413) in the Amount of up to EUR 26,650,000 to be Admitted to Trading on the Regulated Market maturing on 2029 (the ‘Notes), approved by the Bank of Lithuania... (continue reading...)


Bouygues: Very strong nine-month 2026 Group results, Group full-year COPA now expected to increase slightly Nov 5, 2026 01:30AM

Paris, 5 November 2026

PRESS RELEASE

Very strong nine-month 2026 Group resultsGroup full-year COPA now expected to increase slightly

In a particularly volatile macroeconomic and geopolitical environment, the Group turned in a very strong performance in the first nine months of 2026.

  • Group sales were stable at €41.6bn at constant exchange rates (down 0.1% year-on-year1), with growth in the third quarter (up 1.9% at constant exchange rates2).
  • Increase in Group COPA3... (continue reading...)

Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period Nov 5, 2026 01:30AM

Baltic Horizon Fund publishes interest rate applicable to the fund’s 5-year bonds (ISIN: EE3300003235) for the next 3-months interest period which starts on 9 November 2026. The annual interest rate applicable to the bonds for the interest period as referred above is 8% + 2.759% (EURIBOR 3-months) totaling 10.759% per annum.

For additional information, please contact:

Edvinas KarbauskasBaltic Horizon Fund managerE-mail [email protected]... (continue reading...)


More Globe Newswire

View Older Stories

Nov 5, 2026 01:05AM EfTEN United Property Fund unaudited financial results for 3rd quarter and 9 months of 2026
Nov 5, 2026 01:00AM 2026 9 months and III quarter consolidated unaudited interim report
Nov 5, 2026 01:00AM Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update
Nov 5, 2026 01:00AM FTI Consulting Appoints Aurélien Louis to Build on Transactions Capabilities in France
Nov 5, 2026 01:00AM Siemens Healthineers to Rebrand In Vitro Diagnostics Business as Olyrian Diagnostics
Nov 5, 2026 01:00AM Syensqo third quarter 2026 results
Nov 5, 2026 01:00AM IMCD reports EBITA of EUR 425 million (+8%) in the first nine months of 2026
Nov 5, 2026 01:00AM ForFarmers N.V.: Trading update Q3 2026
Nov 5, 2026 01:00AM ArcelorMittal reports third quarter 2026 results
Nov 5, 2026 01:00AM Start of Day Message
Nov 5, 2026 01:00AM 2026 III quarter and 9 months consolidated interim report (unaudited)
Nov 5, 2026 01:00AM IBA signs contract with the Government of Assam for India’s First State-run Proton Therapy Center
Nov 5, 2026 01:00AM WISeQey Advances PKI Modernization as Recent Cyberattacks Highlight the Need to Limit Identity and Credential Risks
Nov 5, 2026 01:00AM Molecular Partners to Present on DLL3-Targeting Radio-DARPin MP0712 at 2026 SNMMI Theranostics Conference and NACLC 2026
Nov 5, 2026 01:00AM NORBIT - Invitation to presentation of NORBIT's third quarter results, 12 November 2026
Nov 5, 2026 01:00AM Zelluna ASA: Third Quarter 2026 results
Nov 5, 2026 01:00AM Interim Report for Q3 2026
Nov 5, 2026 01:00AM VGP NV: Trading Update
Nov 5, 2026 01:00AM Q3 2026 Update: Tecan reports acceleration of sales growth in Q3 and raises full-year 2026 outlook
Nov 5, 2026 01:00AM Lumo Homes Plc: Lumo Homes plc’s Interim Report 1 January–30 September 2026
Nov 5, 2026 01:00AM Bekaert to acquire Dextra, a leading provider of sustainable construction reinforcement solutions
Nov 5, 2026 12:56AM Interim Report Q3 2026: Successful product launches leading to 2% organic revenue growth and margin expansion
Nov 5, 2026 12:32AM Wood Mackenzie: One in five refineries at closure risk as global oil demand peaks in 2032
Nov 5, 2026 12:00AM TTAN Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against ServiceTitan, Inc.
Nov 5, 2026 12:00AM Financial institutions accelerate transition to multi-agent AI in drive for bottom-line value
Nov 4, 2026 11:48PM DOX Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against Amdocs Limited
Nov 4, 2026 10:54PM 2026 Results of Annual General Meeting
Nov 4, 2026 10:45PM DeFi Technologies Announces Shareholder Call to Discuss Q3 2026 Financial Results
Nov 4, 2026 09:29PM Cardinal Point Wealth Management Highlights Estate Planning Considerations for Canadians with U.S. Assets
Nov 4, 2026 09:27PM Fortuna Reports Results for the Third Quarter 2026
Nov 4, 2026 09:11PM From Individual Upgrades to a Complete Workstation: Four Home Office Setup Ideas from Eureka Ergonomic
Nov 4, 2026 09:00PM 3D Systems Announces Agreements to Exchange All Outstanding 5.875% Convertible Senior Secured Notes Due 2030, Eliminating All Secured Debt
Nov 4, 2026 09:00PM NEXSOLACE Presents SUPER GROOMER to Spotlight Professional Pet Grooming Talent
Nov 4, 2026 08:03PM The Manufacturing Foundation Behind AiMOGA and LUXEED: How Chery’s Capabilities Support Two Global Brands
Nov 4, 2026 08:02PM Physical AI Empowers Smart Mobility: LUXEED Builds a New Full-Scenario Intelligent Ecosystem
Nov 4, 2026 08:01PM FlutterFlow Launches AI-Native App Builder for iOS and Android
Nov 4, 2026 08:00PM Backed by Chery's Global NEV Ecosystem, LUXEED Delivers Multi-Scenario Intelligent Luxury Mobility
Nov 4, 2026 08:00PM Backed by Chery's Global NEV Ecosystem, LUXEED Delivers Multi-Scenario Intelligent Luxury Mobility
Nov 4, 2026 08:00PM Cloudbreak Pharma Announces Top-Line Results from its Phase 3 Study of CBT-001 in Patients with Pterygium
Nov 4, 2026 07:53PM Live Oak Bancshares, Inc. Prices Depositary Share Offering
Nov 4, 2026 07:41PM Beyond Meat® Reports Third Quarter 2026 Financial Results
Nov 4, 2026 07:30PM Step Pharma to present data from ongoing phase 2 clinical trial of dencatistat in essential thrombocythaemia at 68th ASH Annual Meeting
Nov 4, 2026 07:14PM Heartland Express, Inc. Announces Participation in Upcoming Conference
Nov 4, 2026 07:11PM Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar
Nov 4, 2026 07:00PM HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia
Nov 4, 2026 07:00PM TaiMed Biologics to Present 24-Week Phase 2a Data on TMB-365/TMB-380 Maintenance Regimen at HIV Glasgow 2026
Nov 4, 2026 06:37PM The Two-Year Brand Project Is Over: EducationDynamics Launches Process That Puts New Brand in Market in 90 Days
Nov 4, 2026 06:30PM Ascentage Pharma to Present Data from Multiple Trials, Including an Oral Presentation of APG-5918 at ASH 2026
Nov 4, 2026 06:30PM Five Star Bancorp Appoints Banking Veteran Christopher D. Myers to its Board of Directors
Nov 4, 2026 06:30PM Five Star Bancorp Appoints Banking Veteran Christopher D. Myers to its Board of Directors
View Older Stories